Delivery Order SPE2DB22D3019-SPE2DB24FK3HL

Award Date 5/7/24
Potential Completion Date 5/8/24
Potential Value $3.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $2,937.88 firm fixed price delivery order is for the supply of 4,565,045,029 methylphenidate extended-release 36mg tablets. The contract has a completion date of July 2, 2024 and does not have a set-aside designation. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to the Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The $2,573.98 firm-fixed-price delivery order is for the supply of 4,564,327,912 tablets of 27 mg extended-release methylphenidate. The contract has an ultimate completion date of April 19, 2024. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA as the primary vehicle for...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the pharmaceutical distribution company Amerisourcebergen Corporation. The $2,286.48 firm fixed-price delivery order is for the supply of 4,564,377,306 methylphenidate extended-release 36mg tablets, with a performance period through April 24, 2024. Amerisourcebergen holds a $999,999,999.00 single-award Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
This federal contract award is for the delivery of 4,564,659,978 tablets of methylphenidate extended-release (10 mg) to the Defense Logistics Agency (DLA), a defense agency under the Department of Defense. The fixed-price, firm-fixed delivery order contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical supplier, for a total ceiling value of $2,153.22. The contract has an ultimate completion date of May 21, 2024. Amerisourcebergen holds a significant Indefinite Delivery...
This federal contract award from the Defense Logistics Agency (DLA) is to Amerisourcebergen Drug Corporation's Corporate Office division, a major supplier of pharmaceutical products and medical supplies to the U.S. government. The $2,513.65 firm fixed price delivery order is for the supply of 4,564,541,466 methylphenidate ER 18 mg tablets, with a period of performance through May 9, 2024. Amerisourcebergen holds a $999,999,999.00 single-award Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, provides methylphenidate extended-release tablets for the Defense Logistics Agency (DLA). The $2,327.56 firm fixed-price delivery order has a completion date of January 25, 2024. Amerisourcebergen holds an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 through November 2026, which serves as the primary vehicle for supplying a wide range of...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor. The $2,238.12 firm-fixed-price delivery order is for the supply of 4,565,020,036 units of 36 mg methylphenidate extended-release tablets. The contract has an ultimate completion date of June 28, 2024. Amerisourcebergen holds two Indefinite Delivery Contracts (IDCs) with federal agencies - a single-award $999,999,999.00 IDC...
This federal contract award is for the delivery of 4,565,153,933 tablets of Methylphenidate ER 36mg to the Defense Logistics Agency (DLA), a component of the Department of Defense (DoD). The $4,943.66 firm fixed price delivery order was awarded to Amerisourcebergen Drug Corp's Corporate Office division, a major pharmaceutical distributor that holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to supply a wide range of medical products to DoD facilities...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is a delivery order worth $7,170.24 and covers the supply of 4,566,176,682 methylphenidate extended-release 27 mg tablets in lots of 100. The contract has a firm fixed price pricing type and an ultimate completion date of October 23, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,566,502,453 units of methylphenidate ER 18 mg tablets in 100-count bottles. The $1,519.44 firm fixed-price Delivery Order (DO) has a completion date of November 21, 2024 and is not subject to any set-aside requirements. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
  • SPE2DB22D3019
    Indefinite Delivery Contract
  • SPE2DB22D3019-SPE2DB24FK3HL
    Delivery Order

This federal contract award was made by the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corp, a subsidiary of the pharmaceutical distribution company Amerisourcebergen Corporation. The $3,526.39 firm fixed-price delivery order is for the supply of 4,564,559,569 methylphenidate extended-release 54 mg tablets in 100-count bottles.

Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The company also holds a smaller IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs, valued up to $750,000 through May 2024. This specific award was not designated as a set-aside contract.

Generated 8/6/24, 10:54 AM